CAR T-Cell Immunotherapy and Future Treatment Applications for Brain Tumor Patients

Dr. Charles Cobbs, Neurosurgeon and Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute in Seattle discusses CAR T-cell immunotherapy and its application to Brain Tumor treatment. For additional articles on this recent research for brain tumor patients, here are some additional links: https://www.cancer.gov/about-cancer/treatment/research/car-t-cells http://www.onclive.com/publications/contemporary-oncology/2014/august-2014/chimeric-antigen-receptor-car-t-cell-immunotherapy-for-leukemia-and-beyond https://www.cirm.ca.gov/agendas/02192015/car-t-cell-immunotherapy-challenges-and-opportunities-using-mature-or-stem-memory-t

UCLA researchers develop promising new combo treatment for deadly brain cancer

A recent article, http://www.newswise.com/articles/ucla-researchers-develop-a-likely-new-combo-treatment-for-the-deadliest-form-of-brain-cancer,  by my colleague Dr. Robert Prins at UCLA  in the prestigious journal Neuro Oncology has drawn significant attention.  Dr. Prins works with Dr. Linda Liau at UCLA developing immunotherapy approaches for treating glioblastoma.  Immunotherapy for cancer is a rapidly evolving field.  To the lay person it can be quite confusing.  There […]

Brain Tumors 101 Series: Surgical Options After A Brain Tumor Diagnosis

BrainCancer.org presents our 9th video in our Brain Tumors 101 series, ” Surgical Options After A Brain Tumor Diagnosis:”. In this video, Dr. Charles Cobbs, Neurosurgeon and the Gregory Foltz Endowed Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment , discusses how surgical resections of brain tumors are approached by […]

Immunotherapy

Transplant drug could boost the power of brain tumor treatments

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   Investigators at the University of Michigan have made headway in one of the most difficult areas of immunotherapy for malignant glioma. http://www.uofmhealth.org/news/archive/201409/transplant-drug-could-boost-power-brain-tumor-treatments-u-m Immunotherapy is the use of a natural immune response […]

Newly Identified Brain Cancer Mutation Hopes To Aid Drug Development

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists     Duke University investigators have recently published and esoteric molecular genetics research finding that may increase our ability to understand the biology of pediatric intrinsic brainstem gliomas.  http://corporate.dukemedicine.org/news_and_publications/news_office/news/newly-identified-brain-cancer-mutation-will-aid-drug-development?utm_source=corporate.dukemedicine.org&utm_medium=rss&utm_campaign=RSS_news These are devastating […]